Valuation check: NOVC.DE's profit margin is 33.92%, above the Healthcare sector average of 21.75%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
As of the most recent data (September 2026), NOVC.DE shows a profit margin of 33.92%. That compares with 32.88% in the prior-year period — up 3.2% year over year. That is above the Healthcare sector average of 21.75%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NOVC.DE's profit margin is now 33.92% (was 32.88%) — a 3.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Novo Nordisk A/S is outperforming or lagging.
The Healthcare sector average profit margin is about 21.75%. Novo Nordisk A/S is at 33.92%, which is higher that average. That is roughly 56.0% above the sector mean. Use the comparison chart on this page to see how NOVC.DE stacks up against individual peers as well.
That compares with 32.88% in the prior-year period — up 3.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Novo Nordisk A/S with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Novo Nordisk A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 33.92%) with ownership activity and broader fundamentals.